Lv11
30 积分 2026-05-27 加入
Comparative Outcomes of Teprotumumab and Tocilizumab in Thyroid Eye Disease: The First Retrospective Study from the United Arab Emirates and Gulf Region of the Middle East
40分钟前
已完结
Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?
45分钟前
求助中
Tocilizumab in Active, Moderate-to-Severe, Glucocorticoid-Resistant Thyroid Eye Disease: An Open-Label Prospective Study in Two Independent Cohorts
1小时前
已完结
Global trends in thyroid cancer 1990–2021: an analysis based on the GBD 2021
17天前
已关闭
The Characteristics of Iodine Nutrition Status in China After 20 Years of Universal Salt Iodization: An Epidemiology Study Covering 31 Provinces
1个月前
已完结
Cigarette Smoking Drives Thyroid Eye Disease Progression via RAGE Signaling Activation
1个月前
已完结
皖公网安备34019202002308
